Current consultation status: Open Consultation period: November 28 to January 28, 2025
Canada’s Drug Agency is launching a consultation on our first ...
Latest News
Canada’s Drug Agency, with support from our health system partners including ICES and Health Data Research Network Canada (HDRN), has published a new ...
Canada’s Drug Agency is pleased to announce the successful applicants from our 2024 Request for Proposals (RFP) to support the enhancement of rare ...
Drug sponsors can now request a flexible service through our Scientific Advice program that can include a shorter time frame.
For Scientific Advice ...
Canada’s Drug Agency has released new guidance around aging in place. This guidance is intended to help health systems address Canada’s demographic ...
Today’s the day: we are officially Canada’s Drug Agency.
We are expanding on our existing mandate and functions — which span drugs, medical devices ...
Upcoming Events
All Upcoming Events12th Annual Data Analytics for Healthcare Summit
Symposium 2024
Symposium 2024 is a 3-day hybrid event that gathers leaders from across Canada with expertise in policy, industry, health technology assessment, patient advocacy, medicine, public health, and communications. The theme of Symposium 2024 is From Disruption to Opportunity: Embracing Change in Health Care.
